Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perampanel monotherapy in newly diagnosed children with focal epilepsy in China
ChiCTR2300068059Phase 4Recruiting
- Sponsor
- Peking University First Hospital
- Start
- Feb 2023
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of perampanel in Focal Onset Epilepsy, sponsored by Peking University First Hospital. Primary endpoint: Proportion of participants without seizures after perampanel treatment. Started Feb 2023; status: recruiting.
02
Drugs
perampanel
03
Conditions
Focal Onset Epilepsy
Beyond the preview
Go deeper on ChiCTR2300068059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300068059.